Patel, Dhaval <br/><br/>
Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma.  [electronic resource] 

 -  Annals of surgical oncology  May 2020 
 - 1338-1347 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1534-4681 
<br/><br/><label>Standard No.: </label>10.1245/s10434-020-08221-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Gland Neoplasms--complications<br/>Adrenalectomy--methods<br/>Adrenergic alpha-Antagonists--therapeutic use<br/>Adrenergic beta-Antagonists--therapeutic use<br/>Calcium Channel Blockers--therapeutic use<br/>Enzyme Inhibitors--therapeutic use<br/>Fluid Therapy<br/>Humans<br/>Hyperinsulinism--diagnosis<br/>Hypertension--drug therapy<br/>Hypoglycemia--diagnosis<br/>Hypotension--diagnosis<br/>Laparoscopy<br/>Multiple Endocrine Neoplasia Type 2a<br/>Multiple Endocrine Neoplasia Type 2b<br/>Neoplasm Recurrence, Local--epidemiology<br/>Paraganglioma--complications<br/>Paraganglioma, Extra-Adrenal--complications<br/>Perioperative Care--methods<br/>Pheochromocytoma--complications<br/>Postoperative Complications--diagnosis<br/>Robotic Surgical Procedures<br/>Treatment Outcome<br/>Tyrosine 3-Monooxygenase--antagonists & inhibitors<br/>Vasoconstrictor Agents--therapeutic use<br/>von Hippel-Lindau Disease